Golkunda Diamonds & Jewellery Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 1:35 pm

Quick Insight

Golkunda Diamonds & Jewellery Ltd, with a current share price of 172 and a market capitalization of 119 Cr., exhibits a moderate P/E ratio of 10.4, indicating a balanced valuation. The company's robust Return on Equity (ROE) and Return on Capital Employed (ROCE) at 19.8% and 19.9%, respectively, reflect efficient capital utilization. However, the operating profit margin (OPM) of 7.10% suggests room for improvement in operational efficiency. With reserves of 58 Cr. and borrowings of ₹36 Cr., Golkunda maintains a healthy financial position, supported by a comfortable Interest Coverage Ratio (ICR) of 6.40x. The Current Cash Conversion Cycle (CCC) of 116 days warrants monitoring for potential working capital optimization. Overall, the company's solid fundamentals and manageable debt levels position it well for growth, contingent on enhancing operational margins.

Competitors of Golkunda Diamonds & Jewellery Ltd

All Competitor Stocks of Golkunda Diamonds & Jewellery Ltd

Quarterly Result

Last Updated: August 19, 2025, 2:30 pm

Below is a detailed analysis of the quarterly data for Golkunda Diamonds & Jewellery Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 69.44 Cr.. The value appears strong and on an upward trend. It has increased from 61.81 Cr. (Mar 2025) to 69.44 Cr., marking an increase of 7.63 Cr..
• For Expenses, as of Jun 2025, the value is 64.51 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 57.93 Cr. (Mar 2025) to 64.51 Cr., marking an increase of 6.58 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.93 Cr.. The value appears strong and on an upward trend. It has increased from 3.88 Cr. (Mar 2025) to 4.93 Cr., marking an increase of 1.05 Cr..
• For OPM %, as of Jun 2025, the value is 7.10%. The value appears strong and on an upward trend. It has increased from 6.28% (Mar 2025) to 7.10%, marking an increase of 0.82%.
• For Other Income, as of Jun 2025, the value is 0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 0.25 Cr. (Mar 2025) to 0.18 Cr., marking a decrease of 0.07 Cr..
• For Interest, as of Jun 2025, the value is 0.63 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.63 Cr..
• For Depreciation, as of Jun 2025, the value is 0.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Mar 2025) to 0.28 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.20 Cr.. The value appears strong and on an upward trend. It has increased from 3.23 Cr. (Mar 2025) to 4.20 Cr., marking an increase of 0.97 Cr..
• For Tax %, as of Jun 2025, the value is 25.24%. The value appears to be improving (decreasing) as expected. It has decreased from 28.79% (Mar 2025) to 25.24%, marking a decrease of 3.55%.
• For Net Profit, as of Jun 2025, the value is 3.14 Cr.. The value appears strong and on an upward trend. It has increased from 2.30 Cr. (Mar 2025) to 3.14 Cr., marking an increase of 0.84 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.51. The value appears strong and on an upward trend. It has increased from 3.30 (Mar 2025) to 4.51, marking an increase of 1.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 1:01 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:11 pm

Below is a detailed analysis of the balance sheet data for Golkunda Diamonds & Jewellery Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
• For Reserves, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 11.00 Cr..
• For Borrowings, as of Mar 2025, the value is 36.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 39.00 Cr. (Mar 2024) to 36.00 Cr., marking a decrease of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Mar 2024) to 27.00 Cr., marking an increase of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 128.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 12.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 118.00 Cr.. The value appears strong and on an upward trend. It has increased from 105.00 Cr. (Mar 2024) to 118.00 Cr., marking an increase of 13.00 Cr..
• For Total Assets, as of Mar 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 116.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 12.00 Cr..

Notably, the Reserves (58.00 Cr.) exceed the Borrowings (36.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Golkunda Diamonds & Jewellery Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.97. This value is within the healthy range. It has increased from 13.81 (Mar 24) to 16.97, marking an increase of 3.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 16.97. This value is within the healthy range. It has increased from 13.81 (Mar 24) to 16.97, marking an increase of 3.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 18.56. This value is within the healthy range. It has increased from 15.24 (Mar 24) to 18.56, marking an increase of 3.32.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 93.91. It has increased from 77.59 (Mar 24) to 93.91, marking an increase of 16.32.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 93.91. It has increased from 77.59 (Mar 24) to 93.91, marking an increase of 16.32.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 362.49. It has increased from 330.94 (Mar 24) to 362.49, marking an increase of 31.55.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 29.41. This value is within the healthy range. It has increased from 24.27 (Mar 24) to 29.41, marking an increase of 5.14.
• For PBIT / Share (Rs.), as of Mar 25, the value is 27.81. This value is within the healthy range. It has increased from 22.83 (Mar 24) to 27.81, marking an increase of 4.98.
• For PBT / Share (Rs.), as of Mar 25, the value is 23.22. This value is within the healthy range. It has increased from 18.51 (Mar 24) to 23.22, marking an increase of 4.71.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 16.97. This value is within the healthy range. It has increased from 13.81 (Mar 24) to 16.97, marking an increase of 3.16.
• For PBDIT Margin (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 10. It has increased from 7.33 (Mar 24) to 8.11, marking an increase of 0.78.
• For PBIT Margin (%), as of Mar 25, the value is 7.67. This value is below the healthy minimum of 10. It has increased from 6.89 (Mar 24) to 7.67, marking an increase of 0.78.
• For PBT Margin (%), as of Mar 25, the value is 6.40. This value is below the healthy minimum of 10. It has increased from 5.59 (Mar 24) to 6.40, marking an increase of 0.81.
• For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from 4.17 (Mar 24) to 4.68, marking an increase of 0.51.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 17.80 (Mar 24) to 18.06, marking an increase of 0.26.
• For Return on Capital Employeed (%), as of Mar 25, the value is 29.13. This value is within the healthy range. It has increased from 28.77 (Mar 24) to 29.13, marking an increase of 0.36.
• For Return On Assets (%), as of Mar 25, the value is 9.20. This value is within the healthy range. It has increased from 8.32 (Mar 24) to 9.20, marking an increase of 0.88.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.55. This value is within the healthy range. It has decreased from 0.72 (Mar 24) to 0.55, marking a decrease of 0.17.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.07. It has decreased from 2.08 (Mar 24) to 2.07, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.75 (Mar 24) to 1.90, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 1.65, marking an increase of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.03. This value exceeds the healthy maximum of 8. It has increased from 12.57 (Mar 24) to 17.03, marking an increase of 4.46.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.85 (Mar 24) to 0.00, marking a decrease of 10.85.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.83 (Mar 24) to 0.00, marking a decrease of 9.83.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.15 (Mar 24) to 0.00, marking a decrease of 89.15.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.17 (Mar 24) to 0.00, marking a decrease of 90.17.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.40. This value is within the healthy range. It has increased from 5.62 (Mar 24) to 6.40, marking an increase of 0.78.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.69. This value is within the healthy range. It has increased from 4.20 (Mar 24) to 4.69, marking an increase of 0.49.
• For Enterprise Value (Cr.), as of Mar 25, the value is 160.43. It has increased from 136.51 (Mar 24) to 160.43, marking an increase of 23.92.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.63, marking an increase of 0.04.
• For EV / EBITDA (X), as of Mar 25, the value is 7.83. This value is within the healthy range. It has decreased from 8.08 (Mar 24) to 7.83, marking a decrease of 0.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.46 (Mar 24) to 0.53, marking an increase of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 89.14 (Mar 24) to 0.00, marking a decrease of 89.14.
• For Price / BV (X), as of Mar 25, the value is 2.08. This value is within the healthy range. It has increased from 2.00 (Mar 24) to 2.08, marking an increase of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.46 (Mar 24) to 0.53, marking an increase of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness